• SENSEX 79,809.65
    -270.92 (--0.34%)
  • BANKNIFTY 53,655.65
    -164.70 (--0.31%)
  • Ola Electric
    53.70 39.58(%)
  • N S D L
    1,226.05 880.00(%)
  • AAVAS Financiers
    1,518.00 1,518.00(%)
  • Waaree Energies
    3,352.25 1,808.65(%)
  • Bharat Electron
    371.10 435.95(%)
  • Godfrey Phillips
    11,400.00 11,462.00(%)
  • Apollo Micro Sys
    271.60 271.60(%)
  • Sammaan Capital
    126.75 174.00(%)
  • Reliance Industr
    1,350.30 1,115.55(%)
  • TCS
    3,077.00 2,992.05(%)
  • Infosys
    1,467.50 1,307.10(%)
  • Jio Financial
    316.70 363.00(%)
  • CG Power & Ind
    699.70 874.50(%)
  • M & M
    3,186.60 2,360.45(%)
  • Maruti Suzuki
    14,850.80 14,940.65(%)
  • Vikram Solar
    334.50 334.05(%)
  • Sun Pharma.Inds.
    1,601.40 1,960.20(%)
  • Vardhman Textile
    422.25 362.60(%)
  • Tata Motors
    668.00 542.55(%)
  • Dr Reddy's Labs
    1,265.65 1,413.97(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shree Ganesh Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71615.0
  • ISIN : INE414Y01015
587.15 -1 (-0.24%)
  • As on 29 Aug 2025 (EOD)

  • Today’s Low

    581.00

  • Today’s High

    605.00

  • Open

    594.05

  • Perv Close

    588.55

  • 52W Low

    500.00

  • 52W High

    950.00

Key Indicators

  • P/E(TTM)

    34.42

  • Mar.Cap (₹Cr.)

    753.70

  • Div & Yield %

    0.00

  • Book Value(₹)

    113.11

  • Debt-Equity Ratio

    -0.24

  • AGM Date

    29-Aug-2025

  • EPS

    17.06

  • P/E Ratio

    34.42

Financials Ratios

  • Debt-Equity Ratio

    0.30

  • Mar.Cap (₹Cr.)

    753.70

  • RONW (%)

    23.02

  • ROCE (%)

    24.40

Score Board

  • Equity (₹ in Cr.)

    12.84

  • BV (₹)

    113.10

  • Sales( ₹ in Cr.)

    108.60

  • NP (in Cr.)

    22.73

  • NP Var(%)

    -19.0

  • Div%

    0.0

  • CPS (₹)

    25.20

  • EPS (₹)

    17.70

  • Traded Value (₹ in Lakhs)

    753.70

  • 52 Week High

    950.00

  • 52 Week Low

    500.00

  • Price BSE

    587.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    753.70

  • P/C Ratio

    23.30

  • P/E Ratio

    33.20

  • Price Vs.BV

    17.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 108.60 125.90 91.36 71.29 49.08 58.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 108.60 125.90 91.36 71.29 49.08 58.43
Other Income 3.73 3.07 0.72 3.57 2.09 4.18
Stock Adjustments 1.52 4.88 0.69 0.40 3.97 -0.08
Total Income 113.85 133.85 92.77 75.26 55.14 62.53
EXPENDITURE :            
Raw Materials 37.52 63.36 48.61 38.11 26.47 35.97
Power and Fuel Cost 7.89 6.39 4.91 4.25 1.34 1.35
Employee Cost 10.12 8.41 5.97 2.95 2.43 2.17
Other Manufacturing Expenses 3.44 0.80 0.51 0.44 1.30 1.32
Selling and Administration Expenses 11.27 9.42 7.02 7.62 7.56 6.30
Miscellaneous Expenses 0.66 0.60 1.60 0.39 0.31 0.28
Employee Benefit Expenses 10.12 8.41 5.97 2.95 2.43 2.17
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 70.91 88.97 68.61 53.77 39.41 47.40
Operating Profit 42.94 44.88 24.16 21.49 15.74 15.12
Interest 2.08 0.60 0.18 0.15 0.07 0.14
Gross Profit 40.86 44.28 23.98 21.34 15.67 14.98
Depreciation 9.57 6.11 3.74 3.34 2.73 2.24
Profit Before Tax 31.29 38.17 20.24 18.00 12.94 12.74
Current Tax 8.24 9.38 5.34 4.65 3.23 3.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.04 0.67 -0.28 -0.04 -0.04 -0.06
Reported Net Profit 23.10 28.12 15.18 13.40 9.75 9.62
Extraordinary Items 0.37 0.13 0.01 -0.03 0.00 0.00
Adjusted Net Profit 22.73 27.99 15.17 13.43 9.75 9.62
Adjustment below Net Profit -0.01 0.05 0.00 -0.08 -1.54 0.00
P & L Balance brought forward 86.73 59.19 44.70 33.15 26.28 18.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.63 0.60 1.75 1.35 1.35
P & L Balance carried down 109.82 86.73 59.28 44.72 33.15 26.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 5.00 3.00 5.00 17.50 15.00
Dividend Per Share(Rs) 0.00 0.50 0.30 0.50 1.75 1.50
Earnings Per Share-Unit Curr 17.99 21.89 12.14 11.16 9.75 10.73
Earnings Per Share(Adj)-Unit Curr 17.99 21.89 12.14 11.08 8.07 7.96
Book Value 113.10 95.07 69.70 51.28 49.97 46.92
Book Value(Adj)-Unit Curr 113.10 95.07 69.70 50.92 41.35 34.81

Shareholding Pattern

  • Promoter Group

    72.80%

  • Public Share Holding

    27.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 10,568 0.08 10,568 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,334,976 72.72 9,334,976 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,345,544 72.80 9,345,544 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,000 0.01 1,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,000 0.01 1,000 1
2] Non Institution
Bodies Corporate 152,811 1.19 152,811 31
Clearing Members 6,036 0.05 6,036 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 88,720 0.69 88,720 251
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 48,580 0.38 48,580 107
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,488,880 11.60 1,488,880 26
Individuals holding nominal share capital up to Rs. 1 lakh 1,704,365 13.28 1,704,365 8,735
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 36 0.00 36 1
Others 1,648 0.01 1,648 2
Sub Total 3,491,076 27.19 3,491,076 9,157
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,837,620 100.00 12,837,620 9,166

Company Background

Shree Ganesh Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Shree Ganesh Remedies Ltd
  • BSE Code : 71615.0
  • ISIN : INE414Y01015

  • Incorporation Year

    1995

  • Registered Office

    Plot No 6011
    GIDC, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-227777

  • FAX

    91-2646-226422

  • Chairman

    Chandubhai Kothia

  • Managing Director

    Chandubhai Kothia

  • Company Secretary

    Aditya Vikrambhai Patel

  • Auditor

    Bansi S Mehta & Co/Chaudhary Shah & Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Shree Ganesh Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shree Ganesh Rem 587.15 112.33 108.60 34.42 19.47
Abbott India 31,497.70 6,684.73 6,409.15 46.09 44.95
Astrazeneca Phar 8,469.45 1,756.92 1,716.29 115.48 32.94
P & G Health Ltd 6,363.75 944.52 934.17 35.14 40.23
Glaxosmi. Pharma 2,783.45 3,866.05 3,723.49 50.05 58.72
Cipla 1,589.65 20,029.57 19,044.85 23.76 21.40
Amrutanjan Healt 688.80 437.58 421.23 36.52 20.84
Guj. Themis Bio. 377.90 152.47 150.80 92.40 27.21
Fermenta Biotec. 317.55 442.21 430.53 10.54 17.61
Bliss GVS Pharma 155.80 703.42 667.20 23.29 9.16
Ambalal Sarabhai 31.40 19.33 4.04 16.44 2.10